
Data presented at the American Academy of Ophthalmology annual meeting from the first head-to-head contralateral study comparing the outcomes of the latest Bausch & Lomb microkeratome technology against the Intralase Femtosecond (FS) device show that the new Bausch & Lomb Zyoptix XP microkeratome:
